These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2893814)

  • 1. Bevantolol disposition in patients with hepatic cirrhosis.
    Nattel S; Lawand S; Matthews C; McCans J
    J Clin Pharmacol; 1987 Dec; 27(12):962-6. PubMed ID: 2893814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of bevantolol hydrochloride, a beta 1-adrenoceptor antagonist, in asthmatic patients.
    Löfdahl CG; Svedmyr K; Svedmyr N
    Pharmacotherapy; 1984; 4(4):205-10. PubMed ID: 6148733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevantolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.
    Frishman WH; Goldberg RJ; Benfield P
    Drugs; 1988 Jan; 35(1):1-21. PubMed ID: 2894292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma bevantolol concentration and heart rate in rabbits.
    Liu XQ; Ye XL; Zhu HQ; Huang SK
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):200-2. PubMed ID: 7901961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of once and twice daily oral dosing schedules of bevantolol, a new beta-adrenoceptor antagonist with alpha-adrenoceptor partial antagonist activity in patients with angina of effort.
    Molajo AO; Bray CL; Hillier V
    Int J Cardiol; 1989 Nov; 25(2):185-92. PubMed ID: 2572566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal hemodynamics and pharmacokinetics of bevantolol in patients with impaired renal function.
    Solimon M; Massry SG; Campese VM
    Am J Cardiol; 1986 Nov; 58(12):21E-24E. PubMed ID: 2878596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of food on the oral absorption of bevantolol.
    Toothaker RD; Randinitis EJ; Nelson C; Kinkel AW; Goulet JR
    J Clin Pharmacol; 1987 Apr; 27(4):297-9. PubMed ID: 2890668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic parameters of bevantolol in volunteers.
    Vermeij P; van Brummelen P
    Eur J Clin Pharmacol; 1986; 30(3):375-7. PubMed ID: 2874033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of bevantolol, a selective beta 1-adrenoceptor antagonist with a novel pharmacological profile.
    Dukes ID; Vaughan Williams EM
    Br J Pharmacol; 1985 Feb; 84(2):365-80. PubMed ID: 2858236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan.
    Noshiro T; Miura Y; Yoshinaga K; Iimura O; Inagaki Y; Saruta T; Ishii M; Yamazaki N; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):240-5. PubMed ID: 7620695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of bevantolol hydrochloride.
    Kaplan HR
    Am J Cardiol; 1986 Nov; 58(12):3E-7E. PubMed ID: 2878599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevantolol: a beta-1 adrenoceptor antagonist with unique additional actions.
    Vaughan Williams EM
    J Clin Pharmacol; 1987 Jul; 27(7):450-60. PubMed ID: 2888789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative single dose and steady-state pharmacokinetics of bevantolol in young and elderly subjects.
    Selen A; Kinkel AW; Darke AC; Greene DS; Welling PG
    Eur J Clin Pharmacol; 1986; 30(6):699-704. PubMed ID: 2876899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and concentration--effect relationships of bevantolol (CI-775) in normal volunteers.
    McNeil JJ; Drummer OH; Anderson AI; Louis WJ
    J Cardiovasc Pharmacol; 1986; 8(6):1201-7. PubMed ID: 2434747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevantolol attenuates thiazide stimulated renin secretion and catecholamine release in diuretic resistant hypertensives.
    Fernandez PG; Snedden W; Vasdev S; Bolli P
    Can J Cardiol; 1989 Mar; 5(2):93-7. PubMed ID: 2565158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca(2+)-antagonistic action of bevantolol on hypothalamic neurons in vitro: its comparison with those of other beta-adrenoceptor antagonists, a local anesthetic and a Ca(2+)-antagonist.
    Omura T; Kobayashi T; Nishioka K; Miyake N; Akaike N
    Brain Res; 1996 Jan; 706(2):289-92. PubMed ID: 8822369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevantolol hydrochloride--preclinical pharmacologic profile.
    Kaplan HR
    Angiology; 1986 Mar; 37(3 Pt 2):254-62. PubMed ID: 2871786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity of bevantolol hydrochloride towards alpha- and beta-adrenoceptor subtypes in rat cerebral cortex.
    Takita M; Kigoshi S; Muramatsu I
    Jpn J Pharmacol; 1992 Feb; 58(2):193-6. PubMed ID: 1354761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics after a single oral dose of bopindolol in patients with cirrhosis.
    Wensing G; Branch RA; Humbert H; Ohnhaus EE; Kirch W
    Eur J Clin Pharmacol; 1990; 39(6):569-72. PubMed ID: 1982762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.